Erratum to: Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine

Erratum to: Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid... Arch Virol (2017) 162:347 DOI 10.1007/s00705-016-3160-9 ERRATUM Erratum to: Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine 1 2 3 4 • • • • Soheila Moeini Mohsen Saeidi Fatemeh Fotouhi Mahdieh Mondanizadeh 5 6,7 8,9 3 • • • Sadegh Shirian Alireza Mohebi Ali Gorji Amir Ghaemi Published online: 24 November 2016 Springer-Verlag Wien 2016 Erratum to: Arch Virol DOI 10.1007/s00705-016-3091-5 Unfortunately, the fourth author name ‘‘Mahdieh Mon- danizadeh’’ was incorrectly published in the original ver- sion. The author name is corrected here and in the original publication as well. The original article was corrected. The online version of the original article can be found under doi:10.1007/s00705-016-3091-5. & Amir Ghaemi ghaem_amir@yahoo.com; a_ghaemi@pasteur.ac.ir Mashhad University of Medical Sciences, Mashhad, Iran Stem Cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran Department of Virology, Pasteur Institute of Iran, P.O.Box: 1316943551, Tehran, Iran Biotechnology and molecular medicine, Arak University of medical sciences, Arak, Iran Department of Pathology, School of Veterinary Medicine, Shahrekord University, Shahrekord, Iran Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran Infectious Diseases Research Center, Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran ¨ ¨ ¨ Institut fur Physiologie I, Westfalische Wilhelms-Universitat Mu¨nster, Robert-Koch-Strasse Mu¨nster, Germany Shefa Neuroscience Research Center, Tehran, Iran http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Virology Springer Journals

Erratum to: Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine

Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/erratum-to-synergistic-effect-of-programmed-cell-death-protein-1-b4k6IiKUaP
Publisher
Springer Vienna
Copyright
Copyright © 2016 by Springer-Verlag Wien
Subject
Biomedicine; Virology; Medical Microbiology; Infectious Diseases
ISSN
0304-8608
eISSN
1432-8798
D.O.I.
10.1007/s00705-016-3160-9
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial